Brokerage Analysts Issue New Ratings and Price Targets on These Shares Today

Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage on November 22nd.

  • DTS (NASDAQ:DTSI): JMP Securities initiated coverage of this company with a rating of Mkt Outperform and a price target of $40. About the company: DTS, Inc. is a provider of digital multi-channel audio technology, products, and services for entertainment markets worldwide. The Company uses the technology in more than two speakers at once, targeted toward motion picture, home theater, and other consumer markets. Get the most recent company news and stock data here >>
  • Dolby Labs (NYSE:DLB): JMP Securities initiated coverage of this company with a rating of Mkt Perform. About the company: Dolby Laboratories Inc. develops audio signal processing systems for the motion picture, broadcasting, and music recording industries, as well as the consumer market. Get the most recent company news and stock data here >>
  • RLJ Lodging Trust (RLJ): Compass Point initiated coverage of this company with a rating of Buy and a price target of $18. Get the most recent company news and stock data here >>
  • Quepasa (QPSA): Rodman & Renshaw initiated coverage of this company with a rating of Mkt Outperform and a price target of $7. Get the most recent company news and stock data here >>
  • Audiovox (NASDAQ:VOXX): Caris & Company initiated coverage of this company with a rating of Above Average and a price target of $10. About the company: Audiovox Corporation markets automobile sound, vehicle security, mobile video systems, and consumer electronics products. The Company markets its products both domestically and internationally under its own brands. Get the most recent company news and stock data here >>
  • Entropic Comms (NASDAQ:ENTR): Mizuho initiated coverage of this company with a rating of Buy and a price target of $7. About the company: Entropic Communications, Inc. designs, develops and outsources the manufacture of, semiconductors. The Company markets semiconductors that enable the home networking of digital entertainment over existing coaxial cable. Get the most recent company news and stock data here >>
  • Och-Ziff Capital (NYSE:OZM): Ticonderoga initiated coverage of this company with a rating of Buy and a price target of $9. About the company: Och-Ziff Capital Management Group manages hedge funds. The Company provides a variety of alternative asset management services for fund investors through locations in the United States, Europe, and Asia. Och-ziff Capital’s investment strategies include private equity, real estate, and equity restructuring. Get the most recent company news and stock data here >>
  • Ziopharm Oncology (NASDAQ:ZIOP): Collins Stewart initiated coverage of this company with a rating of Buy and a price target of $9. About the company: ZIOPHARM Oncology, Inc. is a biopharmaceutical company seeking to acquire, develop and commercialize a diverse, risk-sensitive portfolio of in-licensed cancer drugs. Get the most recent company news and stock data here >>
  • China Kanghui (NYSE:KH): Oppenheimer initiated coverage of this company with a rating of Outperform and a price target of $20. About the company: China Kanghui Holdings, Inc. manufactures orthopedic medical devices. The Company produces trauma supplies including nails, plates and screws, and cranial maxillofacial plate and screw systems; and spinal products including screws, meshes, interbody cages, and fixation systems. Get the most recent company news and stock data here >>
  • Tesla Motors (NASDAQ:TSLA): Wunderlich initiated coverage of this company with a rating of Hold and a price target of $30. About the company: Tesla Motors, Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric powertrain components to other automobile manufacturers. Get the most recent company news and stock data here >>
  • Synergy Resources (SYRG): C.K. Cooper initiated coverage of this company with a rating of Buy and a price target of $6.75. Get the most recent company news and stock data here >>
  • Biomimetic Therapeutics (NASDAQ:BMTI): Collins Stewart initiated coverage of this company with a rating of Buy and a price target of $7. About the company: BioMimetic Therapeutics, Inc. develops and markets drug-device products for the repair of orthopedic injuries to bond, cartilage, ligaments, and tendons. The Company combines protein therapeutics with tissue scaffolds to stimulate tissue healing and regeneration. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Briefing.com via the Wall St. Journal. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>